Losing Weight, Not Your Glow: How to Combat Ozempic Face
Recently, while reviewing my Outlook inbox, I came across an article from the National Library of Medicine that immediately caught my attention: “Ozempic Face: An Emerging Drug-Related Aesthetic Concern.” The article described “Ozempic face” as a prematurely aged, fatigued facial appearance caused by rapid weight loss. My first reaction was disbelief—lose the weight, only to have a telltale sign of GLP-1 drug use show up on your most front-facing asset.
Naturally, I had to dig deeper. I was convinced there had to be ways to counteract this very unwelcome phenomenon.
This is where Bellacara comes in.
My research rabbit hole led me straight to a few products we already carry at Bellacara—most notably SkinCeuticals A.G.E. Interrupter Ultra Serum, released in August 2025. What immediately stood out is that this serum was physician-tested specifically on GLP-1 patients, a remarkably niche group to receive such focused scientific study. That alone made it clear this was not an ordinary product.
The formula is designed to improve skin elasticity using a 34.6% flavo-proxylane solution and to visibly reduce signs of aging, particularly those associated with advanced glycation end-products (AGEs). These AGEs form when sugar molecules bind to collagen, leading to a loss of firmness and elasticity—exactly the type of damage often seen with rapid weight loss.
It is very important to pair this gem with a retinol or retinol alternative to maximize results. My recommendation would be to use the SkinCeuticals Retinol Cream which comes in three strengths: 0.3, 0.5 and 1.0 followed by the A.G.E Interrupter Serum and to lock in this goodness with SkinCeuticals A.G.E. Interrupter Advanced moisturizer.
In short, while GLP-1 medications may change the face of weight loss, targeted, science-backed skincare can help ensure they don’t change your face.
